[Special Stock] Samsung Biologics Recovers to 1 Million Won Level in Four Days

Samsung Biologics rebounded after four days and regained the 1 million KRW mark.

As of 9:17 AM on the 4th, Samsung Biologics is trading at 1,005,000 KRW, up 28,000 KRW (2.87%) from the previous close.

Samsung Biologics recorded a 52-week high of 1.1 million KRW during trading on the 25th of last month but showed a downward trend and fell below 1 million KRW. However, it recovered the 1 million KRW level with an increase close to 3% on this day.

Positive outlooks from securities firms are interpreted to have influenced the stock price rebound. KB Securities raised Samsung Biologics' target price from the previous 1.1 million KRW to 1.26 million KRW, considering the strong dollar and the potential mid- to long-term benefits from the U.S. Biosecurity Act. Daishin Securities also raised the target price from 1 million KRW to 1.2 million KRW, reflecting solid market demand and accelerated revenue recognition from the new factory. Lee Hee-young, a researcher at Daishin Securities, explained, "Starting from the third quarter, revenue from the 4th factory is expected to be recognized in earnest, and the estimated timing for revenue recognition from the 5th to 8th factories, which are scheduled to operate in the future, was advanced from 1.5 years to 1 year, leading to an upward revision of estimates. Additionally, mid- to long-term benefits from the Biosecurity Act are also expected, which contributed to the increase in the target price."